The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diagnosed as having generalized myasthenia gravis and fifteen control cases. AChR Ab assay was done by radio-immunoassay technique and reported by titer in nmole/L. The positive result was defined by titer more than 0.5 nmole/L. In the myasthenia gravis group, age ranged from 18 to 64 years old with mean of 34 years old. The female: male ratio was 4.2:1. Duration of disease before taking blood sample ranged from 1 month to 14 years with a mean of 3.9 year The AChR Ab could be detected in 21 out of 26 patients (80.7%). In the control group, tests were all negative. The results of the test made the sensitivity of 80.7% and specificity of 100%. The positi...
Antibodies to the acetylcholine receptor are the principal pathogenic cause of myasthenia gravis. Th...
Only around 80 % of patients with generalized myasthenia gravis (MG) have serum antibodies to acetyl...
Objective: We developed an assay that detects autoantibodies against the main immunogenic region (MI...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diag-nosed...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diagnosed ...
The acetylcholine receptor (AchR) antibody assay has a key role in the diagnosis of myasthenia gravi...
Background and purpose Anti-acetylcholine receptor (AChR) antibodies (ab) in the serum are detected ...
Background Antibodies against acetylcholine receptor, acetylcholinesterase, ryanodine receptor and t...
INTRODUCTION: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinic...
We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinical severity an...
Acquired myasthenia gravis (MG) is a prototype autoimmune disease of the neuromuscular junction, cau...
Introduction: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinic...
Objective: Acquired myasthenia gravis (MG) is predominantly due to nicotinic acetylcholine receptor ...
Acetylcholine receptor (AChR) antibodies are present in around 85% of patients with myasthenia gravi...
Anti-acetylcholine receptor (AChR) antibody is highly disease-specific to myasthenia gravis (MG) com...
Antibodies to the acetylcholine receptor are the principal pathogenic cause of myasthenia gravis. Th...
Only around 80 % of patients with generalized myasthenia gravis (MG) have serum antibodies to acetyl...
Objective: We developed an assay that detects autoantibodies against the main immunogenic region (MI...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diag-nosed...
The authors studied acetylcholine receptor antibody (AChR Ab) in twenty-six Thai patients diagnosed ...
The acetylcholine receptor (AchR) antibody assay has a key role in the diagnosis of myasthenia gravi...
Background and purpose Anti-acetylcholine receptor (AChR) antibodies (ab) in the serum are detected ...
Background Antibodies against acetylcholine receptor, acetylcholinesterase, ryanodine receptor and t...
INTRODUCTION: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinic...
We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinical severity an...
Acquired myasthenia gravis (MG) is a prototype autoimmune disease of the neuromuscular junction, cau...
Introduction: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinic...
Objective: Acquired myasthenia gravis (MG) is predominantly due to nicotinic acetylcholine receptor ...
Acetylcholine receptor (AChR) antibodies are present in around 85% of patients with myasthenia gravi...
Anti-acetylcholine receptor (AChR) antibody is highly disease-specific to myasthenia gravis (MG) com...
Antibodies to the acetylcholine receptor are the principal pathogenic cause of myasthenia gravis. Th...
Only around 80 % of patients with generalized myasthenia gravis (MG) have serum antibodies to acetyl...
Objective: We developed an assay that detects autoantibodies against the main immunogenic region (MI...